Priority Research Centre for Reproductive Sciences, University of Newcastle, Newcastle, New South Wales, Australia
Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Search for other papers by Sarah J Delforce in
Google Scholar
PubMed
Priority Research Centre for Reproductive Sciences, University of Newcastle, Newcastle, New South Wales, Australia
Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Search for other papers by Eugenie R Lumbers in
Google Scholar
PubMed
Priority Research Centre for Reproductive Sciences, University of Newcastle, Newcastle, New South Wales, Australia
Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Search for other papers by Celine Corbisier de Meaultsart in
Google Scholar
PubMed
Search for other papers by Yu Wang in
Google Scholar
PubMed
Search for other papers by Anthony Proietto in
Google Scholar
PubMed
Search for other papers by Geoffrey Otton in
Google Scholar
PubMed
Search for other papers by Jim Scurry in
Google Scholar
PubMed
Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Priority Research Centre for Cancer, University of Newcastle, Newcastle, New South Wales, Australia
Search for other papers by Nicole M Verrills in
Google Scholar
PubMed
Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Hunter Area Pathology Service, John Hunter Hospital, Newcastle, New South Wales, Australia
Search for other papers by Rodney J Scott in
Google Scholar
PubMed
Priority Research Centre for Reproductive Sciences, University of Newcastle, Newcastle, New South Wales, Australia
Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Search for other papers by Kirsty G Pringle in
Google Scholar
PubMed
Introduction Endometrial cancer is the most common gynaecological malignancy, and the sixth most common cancer in women worldwide, with 320,000 new cases and 76,000 deaths in 2012 ( 1 ). The incidence of endometrial cancer is increasing due to
Search for other papers by Qi Che in
Google Scholar
PubMed
Search for other papers by Xirong Xiao in
Google Scholar
PubMed
Search for other papers by Jun Xu in
Google Scholar
PubMed
Search for other papers by Miao Liu in
Google Scholar
PubMed
Search for other papers by Yongning Lu in
Google Scholar
PubMed
Search for other papers by Suying Liu in
Google Scholar
PubMed
Search for other papers by Xi Dong in
Google Scholar
PubMed
Introduction Endometrial cancer is the fifth most common cancer in females (4.8% of cancers in women), who have a accumulative risk of 1% of developing the disease by age 75 years ( 1 ). Additionally, endometrial adenocarcinomas is separated
Priority Research Centre for Cancer, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales, Australia
Search for other papers by Katherine A Bolton in
Google Scholar
PubMed
Priority Research Centre for Cancer, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales, Australia
Search for other papers by Kelly A Avery-Kiejda in
Google Scholar
PubMed
Clinical Research Design, IT and Statistical Support Unit, Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Search for other papers by Elizabeth G Holliday in
Google Scholar
PubMed
Clinical Research Design, IT and Statistical Support Unit, Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Search for other papers by John Attia in
Google Scholar
PubMed
Priority Research Centre for Cancer, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales, Australia
Search for other papers by Nikola A Bowden in
Google Scholar
PubMed
Priority Research Centre for Cancer, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales, Australia
Molecular Medicine, Pathology North, John Hunter Hospital, Newcastle, New South Wales, Australia
Discipline of Medical Genetics, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, University Drive, Newcastle, New South Wales, Australia
Search for other papers by Rodney J Scott in
Google Scholar
PubMed
Introduction Endometrial cancer is the most common gynaecological malignancy in women from developed countries ( 1 ), and breast cancer is the most common cancer that develops in women worldwide and is responsible for the most female cancer
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by Kirsty G Pringle in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by Sarah J Delforce in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by Yu Wang in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by Katie A Ashton in
Google Scholar
PubMed
Search for other papers by Anthony Proietto in
Google Scholar
PubMed
Search for other papers by Geoffrey Otton in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by C Caroline Blackwell in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Division of Molecular Medicine, Pathology North, Newcastle, New South Wales, Australia
Search for other papers by Rodney J Scott in
Google Scholar
PubMed
Hunter Medical Research Institute, New Lambton, Newcastle, New South Wales, Australia
Search for other papers by Eugenie R Lumbers in
Google Scholar
PubMed
Introduction Endometrial cancer (EC) is the most common gynaecological malignancy and its incidence is increasing. Worldwide, 288,000 women were diagnosed with EC in 2008 ( www.wcrf.org/int/cancer-facts-figures/data-specific-cancers/endometrial-cancer-cancer
Search for other papers by Yali Cheng in
Google Scholar
PubMed
Search for other papers by Qiaoying Lv in
Google Scholar
PubMed
Search for other papers by Bingying Xie in
Google Scholar
PubMed
Search for other papers by Bingyi Yang in
Google Scholar
PubMed
Search for other papers by Weiwei Shan in
Google Scholar
PubMed
Search for other papers by Chengcheng Ning in
Google Scholar
PubMed
Search for other papers by Bing Li in
Google Scholar
PubMed
Search for other papers by Liying Xie in
Google Scholar
PubMed
Search for other papers by Chao Gu in
Google Scholar
PubMed
Search for other papers by Xuezhen Luo in
Google Scholar
PubMed
Search for other papers by Xiaojun Chen in
Google Scholar
PubMed
Search for other papers by Qin Zhu in
Google Scholar
PubMed
Introduction Endometrial cancer (EC) is one of the most common malignant genital tumors among females worldwide, with an estimated 61,380 new cases in America in 2017 ( 1 ). It is known that type1 EC is estrogen-dependent tumor. Sustained
Search for other papers by Keina Nishio in
Google Scholar
PubMed
Search for other papers by Akiko Tanabe in
Google Scholar
PubMed
Search for other papers by Risa Maruoka in
Google Scholar
PubMed
Search for other papers by Kiyoko Nakamura in
Google Scholar
PubMed
Search for other papers by Masaaki Takai in
Google Scholar
PubMed
Search for other papers by Tatsuharu Sekijima in
Google Scholar
PubMed
Search for other papers by Satoshi Tunetoh in
Google Scholar
PubMed
Search for other papers by Yoshito Terai in
Google Scholar
PubMed
Search for other papers by Masahide Ohmichi in
Google Scholar
PubMed
Introduction Cancer survivors are living longer after the initial diagnosis of cancer due to earlier diagnosis and improved cancer treatments. Epithelial ovarian cancer (OC), uterine endometrial cancer (EC), and cervical cancer (CC) are major
Search for other papers by Abdul K Siraj in
Google Scholar
PubMed
Search for other papers by Rong Bu in
Google Scholar
PubMed
Search for other papers by Maham Arshad in
Google Scholar
PubMed
Search for other papers by Kaleem Iqbal in
Google Scholar
PubMed
Search for other papers by Sandeep Kumar Parvathareddy in
Google Scholar
PubMed
Search for other papers by Tariq Masoodi in
Google Scholar
PubMed
Search for other papers by Laila Omar Ghazwani in
Google Scholar
PubMed
Search for other papers by Saif S Al-Sobhi in
Google Scholar
PubMed
Search for other papers by Fouad Al-Dayel in
Google Scholar
PubMed
Search for other papers by Khawla S Al-Kuraya in
Google Scholar
PubMed
identified germline pathogenic variants in the exonuclease domain of POLE and POLD1 which predispose, with a high penetrance, to multiple and/or large colorectal adenomas, early-onset colorectal cancer (CRC) as well as endometrial cancer in female
Search for other papers by Zherui Fu in
Google Scholar
PubMed
Search for other papers by Yi Lai in
Google Scholar
PubMed
Search for other papers by Qianfei Wang in
Google Scholar
PubMed
Search for other papers by Feng Lin in
Google Scholar
PubMed
Search for other papers by Jiaping Fang in
Google Scholar
PubMed
Introduction Thyroid cancer is one of the most common malignant tumors of the endocrine system, accounting for 2% of all malignant tumors. The incidence of thyroid cancer has rapidly increased in recent decades, which is a significant concern
Division of Endocrinology, Department of Medicine, Medstar Washington Hospital Center, Washington Hospital Center, Northwest, Washington, District of Columbia, USA
Search for other papers by Joanna Klubo-Gwiezdzinska in
Google Scholar
PubMed
Search for other papers by John Costello Jr in
Google Scholar
PubMed
Search for other papers by Kirk Jensen in
Google Scholar
PubMed
Search for other papers by Aneeta Patel in
Google Scholar
PubMed
Search for other papers by Rok Tkavc in
Google Scholar
PubMed
Search for other papers by Douglas Van Nostrand in
Google Scholar
PubMed
Search for other papers by Kenneth D Burman in
Google Scholar
PubMed
Search for other papers by Leonard Wartofsky in
Google Scholar
PubMed
Search for other papers by Vasyl Vasko in
Google Scholar
PubMed
responsible for differential response to amifostine between normal and cancer cells in vivo ( 20 ). Luo and coworkers documented that sensitivity of endometrial cancer cells to the therapeutic effect of paclitaxel in combination with amifostine was dependent
Search for other papers by Yuan Fang in
Google Scholar
PubMed
Search for other papers by Xuehong Zhang in
Google Scholar
PubMed
Search for other papers by Huilin Xu in
Google Scholar
PubMed
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA
Search for other papers by Stephanie A Smith-Warner in
Google Scholar
PubMed
Search for other papers by Dongli Xu in
Google Scholar
PubMed
Search for other papers by Hong Fang in
Google Scholar
PubMed
Search for other papers by Wang Hong Xu in
Google Scholar
PubMed
the strongest associations being observed for liver, pancreatic and endometrial cancers and more moderate associations observed for breast, colorectal and bladder cancer. An inverse association has been consistently observed for prostate cancer, while